C
CDBT
vs
S&P 500
S&P 500
Over the past 12 months, CDBT has underperformed S&P 500, delivering a return of -34% compared to the S&P 500's +17% growth.
Stocks Performance
CDBT vs S&P 500
Performance Gap
CDBT vs S&P 500
Performance By Year
CDBT vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
China Dasheng Biotechnology Co
Glance View
China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.